Skip to main content
SpringerLink
Log in

Everolimus/temsirolimus

Drug-induced interstitial lung disease: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nagase H, et al. Incidence and clinical features of mTOR inhibitor-induced interstitial lung disease. American Journal of Respiratory and Critical Care Medicine 185: abstr. A1596, 2012 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Everolimus/temsirolimus. Reactions Weekly 1569, 107 (2015). https://doi.org/10.1007/s40278-015-5451-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-5451-4

Search

Navigation